Corbus Pharmaceuticals Holdi

Stocks Under $10 Biotech Stocks Healthcare Stocks

$6.13

-0.21 (-3.31%)

As of Oct 3, 2:27 AM ET ·

Analyst Consensus

Strong Buy

Analysts

High

Coverage

Buy 15 94%

Hold 1 6%

Sell 0 0%

Price Target

Analyst Price Target +98.2% upside

Low Target $8.71

Average Target $12.15

High Target $17.60

Current Price $6.13

Current
$6.13

Target
$12.15

$8.71 $12.15 avg $17.60

Scenario Analysis

Bear Case

$8.71

42.1%

Low target

Base Case

$12.15

+98.2%

Avg target

Bull Case

$17.60

+187.1%

High target

Risk/Reward

4.4x

Highly favorable

Price in Context

52-Week High

$20.56

-70.2% from high

52-Week Low

$6.25

+-1.9% from low

Target vs 52W High

$12.15

-40.9% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	39	82%	$257.58	-2.0%
AMGN Amgen Inc	Hold	43	47%	$190.87	-52.6%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+150.6%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	36	81%	$438.34	-13.2%
MRNA Moderna Inc	Hold	30	37%	$149.45	-21.3%
REGN Regeneron Pharmaceuticals	Buy	38	68%	$76.80	-89.6%
NTRA Natera Inc	Strong Buy	30	87%	$142.91	-65.2%
RVMD Revolution Medicines Inc	Strong Buy	28	93%	$114.11	-44.8%